About this page
NTLA — Intellia Therapeutics
Why Intellia Therapeutics (NTLA) moved: the last session's move split into the market, its industry, its themes and the part unique to the company, with our latest explained moves and their sources, beside the live chart.
On Friday, November 20, 2026, Intellia Therapeutics (NTLA) rose 5.04% at the close. Where it came from: Market (SPY) -8.38%, High-Growth Innovation +1.88%, Biotechnology +1.01%, Factors (6) +1.00%, Unique to NTLA +9.53%. Most of NTLA's gain was unique to the stock; the market detracted.
Intellia Therapeutics (NTLA) last reported earnings on Thursday, November 12, 2026, after the close (SEC 8-K); the next session, Friday, November 13, 2026, NTLA fell 8.06% at the close. Its next report is estimated for about Thursday, February 4, 2027 (between February 2 and February 6), before the open, from its own rhythm across 12 reports; not yet announced. The earnings calendar.
TickerTiles has explained one of NTLA's moves in the last six months — Friday, November 20, 2026 (rose 5.0%). The catalyst behind each, with its sources, is on this page.
Each explained move has its own page: Friday, November 20, 2026.
Only on this page: NTLA's split updating every minute while the market is open, which of the 6 factors moved it and by how much, and the catalyst behind its explained move, with sources.
Explore daily moves on this page shows where NTLA's moves came from, session by session — the market, its industry, its themes, its factors and its own part. The month and three-month views are free; six months, the year to date and the full year, with every day's breakdown and its full explanation, are part of TickerTiles Plus.
All stocks: Why stocks moved. The whole market: Market Overview.